Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18
about
Memory of infections: an emerging role for natural killer cellsBioactive Molecules Released From Cells Infected with the Human CytomegalovirusHuman cytomegalovirus infection elicits new decidual natural killer cell effector functions.Harnessing adaptive natural killer cells in cancer immunotherapyPlasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141Quantitative temporal viromics: an approach to investigate host-pathogen interactionHCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells.The AgrD N-terminal leader peptide of Staphylococcus aureus has cytolytic and amyloidogenic properties.Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions.High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination.Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient PatientsBroadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses.Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.Leukocyte Immunoglobulin-Like Receptor 1-Expressing Human Natural Killer Cell Subsets Differentially Recognize Isolates of Human Cytomegalovirus through the Viral Major Histocompatibility Complex Class I Homolog UL18.A new immunization and treatment strategy for mouse mammary tumor virus (MMTV) associated cancers.Analysis of the cross-talk of Epstein-Barr virus-infected B cells with T cells in the marmoset.Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.Roles of regulated intramembrane proteolysis in virus infection and antiviral immunity.Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?Enhancement of cytokine-driven NK cell IFN-γ production after vaccination of HCMV infected Africans.Cytomegalovirus-Infected Cells Resist T Cell Mediated Killing in an HLA-Recognition Independent Manner.Bruton's agammaglobulinemia in an adult male due to a novel mutation: a case report.Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle.The Folate Cycle As a Cause of Natural Killer Cell Dysfunction and Viral Etiology in Type 1 Diabetes.Origins of Natural Killer Cell Memory: Special Creation or Adaptive Evolution.CMV and natural killer cells: shaping the response to vaccination.Herpesvirus Evasion of Natural Killer Cells.HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.HCMV-Encoded NK Modulators: Lessons From and Genetic VariationHLA-E Peptide Repertoire and Dimorphism-Centerpieces in the Adaptive NK Cell Puzzle?
P2860
Q21131375-319B872C-0A3C-4168-8E84-2DE5E47458F2Q26744665-DB54C9E7-1EB9-4950-843A-0E229DC5660AQ27335494-2DE3B093-DFF4-4539-82E8-5D5D5FE56068Q28081448-E207F275-FD28-48F4-A97A-982E6FBA7197Q28546343-B9DCF514-D5A8-4E7F-BC27-8A0D09131E7FQ33722378-113275EE-4A1B-4142-8EB6-E45C34ECFF94Q34116205-202A3CA9-B131-451E-96E5-35B47BF33BB6Q34298514-F289C1FD-2AB7-436A-B1BE-20B72FFFBAA6Q34390895-46C1ED4F-A47F-4433-9C65-40CA836013BDQ35861195-7C843152-0D4A-4E4B-89A5-2DB17A5DA2BEQ36123419-529521A7-64A0-441E-A5F7-0A85513A101CQ36624194-383A0580-4198-4894-A64C-E2C18E1AA476Q36695499-08D5C851-2076-45EB-AC3E-7C788F9DECB9Q36708679-D4E97909-5E90-4E4E-9A22-31630A270932Q36736566-AB96D6EA-85A9-4029-A083-D65686BC1651Q37225242-B4FBD8C6-440F-4E0E-B5AC-773A2EE9F7AFQ37644275-44A0C2D5-7089-4826-9190-4C71EEF45800Q38009207-AB4B46BC-370C-471C-B63E-CB039EC97618Q38095771-0520BBC9-90FA-4CA6-A171-FB14E4193E81Q38149888-DE3044BD-5E52-460D-A211-B7E632A3960FQ38270735-984290EA-935C-4131-8C92-68FA34971D93Q38850734-15C77A04-7B02-490B-9184-E6DD2CADF4C5Q39634413-0B6A333D-2A1A-47EA-8E6D-2407F664732DQ40443234-D931CEBF-D4D8-441E-8F11-5A9404FEE434Q40922609-7E838719-6C71-43F9-A206-A6EB6AA3ACDDQ47224028-BF1E8C9B-2B85-41C9-B4E8-6D9A28EC7AD6Q47550532-2969D385-B6DA-4BA1-90C5-2110C62597F0Q48273032-07C00B8F-CEFE-43C2-8B05-48546B9EA2AEQ54255834-D62E089B-2E3C-453D-A135-266699256025Q55002157-65E3586C-005E-4DFB-A0AE-3F6A3335A2C9Q57486496-3BCAC339-438B-49E4-86B3-3A6DCFB1E460Q58606323-A80BADC6-5732-45DD-B7A8-6F52F2416E50
P2860
Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Human cytomegalovirus UL40 sig ...... cell ligands HLA-E and gpUL18
@ast
Human cytomegalovirus UL40 sig ...... cell ligands HLA-E and gpUL18
@en
type
label
Human cytomegalovirus UL40 sig ...... cell ligands HLA-E and gpUL18
@ast
Human cytomegalovirus UL40 sig ...... cell ligands HLA-E and gpUL18
@en
prefLabel
Human cytomegalovirus UL40 sig ...... cell ligands HLA-E and gpUL18
@ast
Human cytomegalovirus UL40 sig ...... cell ligands HLA-E and gpUL18
@en
P2093
P2860
P50
P356
P1476
Human cytomegalovirus UL40 sig ...... cell ligands HLA-E and gpUL18
@en
P2093
Andrew J Davison
Bruno Martoglio
Charles Cunningham
Gavin W G Wilkinson
Peter Tomasec
Simone Cuff
P2860
P304
P356
10.4049/JIMMUNOL.1102068
P407
P577
2012-02-15T00:00:00Z